Maxim Group Downgrades IntelliPharmaCeutics International (IPCI) to Hold

February 16, 2018 2:02 PM EST Send to a Friend
Maxim Group downgraded IntelliPharmaCeutics International (NASDAQ: IPCI) from Buy to Hold.Analyst Jason Kolbert commented, "The cash balance is low and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login